The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: clonazepam     Quarter: 2016Q3

Total Records: 516     Number of Pages: 26

DRUGNAME PT EventCount
CLONAZEPAM 0.5MG Fatigue 2
CLONAZEPAM 0.5MG Gastrointestinal disorder 2
CLONAZEPAM 0.5MG Localised infection 2
CLONAZEPAM 0.5MG Muscle tightness 2
CLONAZEPAM 0.5MG Nervousness 2
CLONAZEPAM 0.5MG Pain in extremity 2
CLONAZEPAM 0.5MG Panic attack 2
CLONAZEPAM 0.5MG Product colour issue 2
CLONAZEPAM 0.5MG Product quality issue 2
CLONAZEPAM 0.5MG Product solubility abnormal 2
CLONAZEPAM 0.5MG Pruritus 2
CLONAZEPAM 0.5MG Rosacea 2
CLONAZEPAM 0.5MG Sensation of foreign body 2
CLONAZEPAM 0.5MG Somnolence 2
CLONAZEPAM 0.5MG Stress 2
CLONAZEPAM 0.5MG Withdrawal syndrome 2
CLONAZEPAM 0.5MG Wrong technique in product usage process 2
CLONAZEPAM 1MG Drug effect decreased 2
CLONAZEPAM 1MG Product use issue 2
CLONAZEPAM 1MG Therapeutic response increased 2

Total Records: 516     Number of Pages: 26